Bristol-Myers Squibb Company is a company in the U.S. stock market and it is a holding in 225 U.S.-traded ETFs. BMY has around 168.8M shares in the U.S. ETF market. The largest ETF holder of BMY is the SPDR S&P 500 ETF Trust (SPY), with approximately 25.38M shares. Investors may also find of interest that the ETF with the largest allocation to BMY stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 7.87%. On average, U.S. ETFs allocate 1.06% of BMY to their portfolios.
Additionally, BMY is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BMY as a holding is the AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL), with a return of 17.61%.